903 research outputs found

    Predictive model for acute myocardial infarction in working-age population: a machine learning approach

    Get PDF
    Cardiovascular diseases are the leading cause of mortality in Latin America, particularly acute myocardial infarction (AMI), which is the primary cause of atherosclerotic cardiovascular morbidity. This study aims to develop a predictive model for the probability of AMI occurrence in the working-age population, based on atherogenic indices, paraclinical variables, and anthropometric measures. The research conducted a cross-sectional study involving 427 workers aged 40 years or older in Popayán, Colombia. Out of this population, 202 individuals were screened with a 95% confidence interval and a 5% error margin. Epidemiological, anthropometric, and paraclinical data were collected. A binary logistic regression model was employed to identify variables directly associated with the probability of AMI. Predictive classification models were generated using statistical software JASP and the programming language Python. During the training stage, JASP produced a model with an accuracy of 87.5%, while Python generated a model with an accuracy of 90.2%. In the validation stage, JASP achieved an accuracy of 93%, and Python reached 95%. These results establish an effective model for predicting the probability of AMI in the working population

    Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells

    Get PDF
    Cervical cancer (CC) is a major global health problem and leading cause of cancer deaths among women worldwide. Early detection through screening programs has reduced mortality; however, screening compliance remains low. Identifying non-invasive biomarkers through proteomics for diagnosis and monitoring response to treatment could improve patient outcomes. Here we review recent proteomics studies which have uncovered biomarkers and potential drug targets for CC. Additionally, we explore into the role of cervical cancer stem cells and their potential implications in driving CC progression and therapy resistance. Although challenges remain, proteomics has the potential to revolutionize the field of cervical cancer research and improve patient outcomes

    Multidisciplinary perspectives on Artificial Intelligence and the law

    Get PDF
    This open access book presents an interdisciplinary, multi-authored, edited collection of chapters on Artificial Intelligence (‘AI’) and the Law. AI technology has come to play a central role in the modern data economy. Through a combination of increased computing power, the growing availability of data and the advancement of algorithms, AI has now become an umbrella term for some of the most transformational technological breakthroughs of this age. The importance of AI stems from both the opportunities that it offers and the challenges that it entails. While AI applications hold the promise of economic growth and efficiency gains, they also create significant risks and uncertainty. The potential and perils of AI have thus come to dominate modern discussions of technology and ethics – and although AI was initially allowed to largely develop without guidelines or rules, few would deny that the law is set to play a fundamental role in shaping the future of AI. As the debate over AI is far from over, the need for rigorous analysis has never been greater. This book thus brings together contributors from different fields and backgrounds to explore how the law might provide answers to some of the most pressing questions raised by AI. An outcome of the Católica Research Centre for the Future of Law and its interdisciplinary working group on Law and Artificial Intelligence, it includes contributions by leading scholars in the fields of technology, ethics and the law.info:eu-repo/semantics/publishedVersio

    Toward a new era of cancer detection: patient-friendly solutions

    Get PDF
    SUMMARY High cancer mortality rates and the rising cancer burden worldwide prioritize the development of innovative methods that facilitate the early and accurate detection of cancer. Combining patient-friendly sampling methods with reliable biomarker testing offers a method that is convenient for patients and effective in detecting cancer at a curable stage, with improved patient outcomes as an ultimate goal. This thesis assessed the feasibility of DNA methylation testing in urine as a diagnostic tool for different cancer types, including endometrial, ovarian, and lung cancer. For endometrial and ovarian cancer, the value of DNA methylation testing in self-collected cervicovaginal samples and clinician-taken cervical scrapes was also investigated. Part 1: Endometrial and ovarian cancer detection in patient-friendly samples Part 1 describes the detection of endometrial and ovarian cancer in urine, cervicovaginal self-samples, and clinician-taken cervical scrapes. The outcomes of Part 1 revealed the value of methylation analysis in patient-friendly sample types for endometrial cancer detection of all stages. Convenient modes of sample collection offer the possibility of at-home collection with high patient acceptability. This approach is clinically useful to screen patient populations at risk for endometrial cancer and to streamline who needs to undergo invasive endometrial tissue sampling. Although promising, the clinical effectiveness of this approach requires further confirmation in additional cohorts, including individuals presenting with postmenopausal bleeding and asymptomatic women at risk for endometrial cancer. The presence of ovarian cancer-derived DNA in the urine provides the first steps toward urine-based diagnostics for ovarian cancer. Further research is needed to further explore and refine the use of urine biomarkers for ovarian cancer diagnostics. Part 2: Non-small cell lung cancer detection in urine In Part 2 of this thesis, the diagnostic potential of urine as a liquid biopsy for non-small cell lung cancer (NSCLC) detection was evaluated. The outcomes of Part 2 demonstrate the technical feasibility of detecting NSCLC in the urine using DNA methylation markers. Further research, including larger patient cohorts and controls with benign pulmonary nodules, is needed to validate the clinical usefulness of this approach. The considerable variability between urine samples highlights the need for a more thorough understanding of cfDNA dynamics and enhancements in test development to ensure reliability. Upon further refinement, this test has the potential to serve as a valuable complementary diagnostic tool to low-dose CT screening to guide clinical decisions in patients with pulmonary nodules

    An Industry Framework for Remote Health Monitoring using Machine Learning Models to Predict a Disease

    Get PDF
    Remote health monitoring frameworks gained significant attention due to their real intervention and treatment standards. Most conventional works object to developing remote monitoring frameworks for identifying the disease at the earlier stages for an appropriate diagnosis. Still, it faced the problems with complexity in operations, increased cost of resources, misprediction results, which requires more time consumption for data gathering, and reduced convergence rate. Hence, the proposed work intends to design a machine learning based remote health monitoring framework for predicting heart disease and diabetes from the given medical datasets. In this framework, the Industry based smart devices are used to gather the health information of patients, and the obtained information is integrated together by using different nodes that includes the detecting node, visualization node, and prognostic node. Then, the medical dataset preprocessing is performed to normalize the attributes by identifying the missing values and eliminating the irrelevant qualities. Consequently, the Unified Levy Modeled Crow Search Optimization (U-CSO) algorithm is employed to select the optimal features based on the global fitness function, which helps increase the accuracy and reduce the training time of the classifier. Finally, the Most Probabilistic Guided Naïve Distribution (MP-ND) based classification model is utilized for predicting the label as to whether normal or disease affected. During an evaluation, two different datasets, such as PIMA and Hungarian, are used to validate and compare the results of the proposed model by using various performance measures. A Patients' health status can be monitored remotely for disease detection and proper diagnosis

    30th European Congress on Obesity (ECO 2023)

    Get PDF
    This is the abstract book of 30th European Congress on Obesity (ECO 2023

    Improving diagnostic procedures for epilepsy through automated recording and analysis of patients’ history

    Get PDF
    Transient loss of consciousness (TLOC) is a time-limited state of profound cognitive impairment characterised by amnesia, abnormal motor control, loss of responsiveness, a short duration and complete recovery. Most instances of TLOC are caused by one of three health conditions: epilepsy, functional (dissociative) seizures (FDS), or syncope. There is often a delay before the correct diagnosis is made and 10-20% of individuals initially receive an incorrect diagnosis. Clinical decision tools based on the endorsement of TLOC symptom lists have been limited to distinguishing between two causes of TLOC. The Initial Paroxysmal Event Profile (iPEP) has shown promise but was demonstrated to have greater accuracy in distinguishing between syncope and epilepsy or FDS than between epilepsy and FDS. The objective of this thesis was to investigate whether interactional, linguistic, and communicative differences in how people with epilepsy and people with FDS describe their experiences of TLOC can improve the predictive performance of the iPEP. An online web application was designed that collected information about TLOC symptoms and medical history from patients and witnesses using a binary questionnaire and verbal interaction with a virtual agent. We explored potential methods of automatically detecting these communicative differences, whether the differences were present during an interaction with a VA, to what extent these automatically detectable communicative differences improve the performance of the iPEP, and the acceptability of the application from the perspective of patients and witnesses. The two feature sets that were applied to previous doctor-patient interactions, features designed to measure formulation effort or detect semantic differences between the two groups, were able to predict the diagnosis with an accuracy of 71% and 81%, respectively. Individuals with epilepsy or FDS provided descriptions of TLOC to the VA that were qualitatively like those observed in previous research. Both feature sets were effective predictors of the diagnosis when applied to the web application recordings (85.7% and 85.7%). Overall, the accuracy of machine learning models trained for the threeway classification between epilepsy, FDS, and syncope using the iPEP responses from patients that were collected through the web application was worse than the performance observed in previous research (65.8% vs 78.3%), but the performance was increased by the inclusion of features extracted from the spoken descriptions on TLOC (85.5%). Finally, most participants who provided feedback reported that the online application was acceptable. These findings suggest that it is feasible to differentiate between people with epilepsy and people with FDS using an automated analysis of spoken seizure descriptions. Furthermore, incorporating these features into a clinical decision tool for TLOC can improve the predictive performance by improving the differential diagnosis between these two health conditions. Future research should use the feedback to improve the design of the application and increase perceived acceptability of the approach

    A novel gluten knowledge base of potential biomedical and health-related interactions extracted from the literature: using machine learning and graph analysis methodologies to reconstruct the bibliome

    Get PDF
    Background In return for their nutritional properties and broad availability, cereal crops have been associated with different alimentary disorders and symptoms, with the majority of the responsibility being attributed to gluten. Therefore, the research of gluten-related literature data continues to be produced at ever-growing rates, driven in part by the recent exploratory studies that link gluten to non-traditional diseases and the popularity of gluten-free diets, making it increasingly difficult to access and analyse practical and structured information. In this sense, the accelerated discovery of novel advances in diagnosis and treatment, as well as exploratory studies, produce a favourable scenario for disinformation and misinformation. Objectives Aligned with, the European Union strategy “Delivering on EU Food Safety and Nutrition in 2050″ which emphasizes the inextricable links between imbalanced diets, the increased exposure to unreliable sources of information and misleading information, and the increased dependency on reliable sources of information; this paper presents GlutKNOIS, a public and interactive literature-based database that reconstructs and represents the experimental biomedical knowledge extracted from the gluten-related literature. The developed platform includes different external database knowledge, bibliometrics statistics and social media discussion to propose a novel and enhanced way to search, visualise and analyse potential biomedical and health-related interactions in relation to the gluten domain. Methods For this purpose, the presented study applies a semi-supervised curation workflow that combines natural language processing techniques, machine learning algorithms, ontology-based normalization and integration approaches, named entity recognition methods, and graph knowledge reconstruction methodologies to process, classify, represent and analyse the experimental findings contained in the literature, which is also complemented by data from the social discussion. Results and conclusions In this sense, 5814 documents were manually annotated and 7424 were fully automatically processed to reconstruct the first online gluten-related knowledge database of evidenced health-related interactions that produce health or metabolic changes based on the literature. In addition, the automatic processing of the literature combined with the knowledge representation methodologies proposed has the potential to assist in the revision and analysis of years of gluten research. The reconstructed knowledge base is public and accessible at https://sing-group.org/glutknois/Fundação para a Ciência e a Tecnologia | Ref. UIDB/50006/2020Xunta de Galicia | Ref. ED481B-2019-032Xunta de Galicia | Ref. ED431G2019/06Xunta de Galicia | Ref. ED431C 2022/03Universidade de Vigo/CISU

    Anwendungen maschinellen Lernens für datengetriebene Prävention auf Populationsebene

    Get PDF
    Healthcare costs are systematically rising, and current therapy-focused healthcare systems are not sustainable in the long run. While disease prevention is a viable instrument for reducing costs and suffering, it requires risk modeling to stratify populations, identify high- risk individuals and enable personalized interventions. In current clinical practice, however, systematic risk stratification is limited: on the one hand, for the vast majority of endpoints, no risk models exist. On the other hand, available models focus on predicting a single disease at a time, rendering predictor collection burdensome. At the same time, the den- sity of individual patient data is constantly increasing. Especially complex data modalities, such as -omics measurements or images, may contain systemic information on future health trajectories relevant for multiple endpoints simultaneously. However, to date, this data is inaccessible for risk modeling as no dedicated methods exist to extract clinically relevant information. This study built on recent advances in machine learning to investigate the ap- plicability of four distinct data modalities not yet leveraged for risk modeling in primary prevention. For each data modality, a neural network-based survival model was developed to extract predictive information, scrutinize performance gains over commonly collected covariates, and pinpoint potential clinical utility. Notably, the developed methodology was able to integrate polygenic risk scores for cardiovascular prevention, outperforming existing approaches and identifying benefiting subpopulations. Investigating NMR metabolomics, the developed methodology allowed the prediction of future disease onset for many common diseases at once, indicating potential applicability as a drop-in replacement for commonly collected covariates. Extending the methodology to phenome-wide risk modeling, elec- tronic health records were found to be a general source of predictive information with high systemic relevance for thousands of endpoints. Assessing retinal fundus photographs, the developed methodology identified diseases where retinal information most impacted health trajectories. In summary, the results demonstrate the capability of neural survival models to integrate complex data modalities for multi-disease risk modeling in primary prevention and illustrate the tremendous potential of machine learning models to disrupt medical practice toward data-driven prevention at population scale.Die Kosten im Gesundheitswesen steigen systematisch und derzeitige therapieorientierte Gesundheitssysteme sind nicht nachhaltig. Angesichts vieler verhinderbarer Krankheiten stellt die Prävention ein veritables Instrument zur Verringerung von Kosten und Leiden dar. Risikostratifizierung ist die grundlegende Voraussetzung für ein präventionszentri- ertes Gesundheitswesen um Personen mit hohem Risiko zu identifizieren und Maßnah- men einzuleiten. Heute ist eine systematische Risikostratifizierung jedoch nur begrenzt möglich, da für die meisten Krankheiten keine Risikomodelle existieren und sich verfüg- bare Modelle auf einzelne Krankheiten beschränken. Weil für deren Berechnung jeweils spezielle Sets an Prädiktoren zu erheben sind werden in Praxis oft nur wenige Modelle angewandt. Gleichzeitig versprechen komplexe Datenmodalitäten, wie Bilder oder -omics- Messungen, systemische Informationen über zukünftige Gesundheitsverläufe, mit poten- tieller Relevanz für viele Endpunkte gleichzeitig. Da es an dedizierten Methoden zur Ex- traktion klinisch relevanter Informationen fehlt, sind diese Daten jedoch für die Risikomod- ellierung unzugänglich, und ihr Potenzial blieb bislang unbewertet. Diese Studie nutzt ma- chinelles Lernen, um die Anwendbarkeit von vier Datenmodalitäten in der Primärpräven- tion zu untersuchen: polygene Risikoscores für die kardiovaskuläre Prävention, NMR Meta- bolomicsdaten, elektronische Gesundheitsakten und Netzhautfundusfotos. Pro Datenmodal- ität wurde ein neuronales Risikomodell entwickelt, um relevante Informationen zu extra- hieren, additive Information gegenüber üblicherweise erfassten Kovariaten zu quantifizieren und den potenziellen klinischen Nutzen der Datenmodalität zu ermitteln. Die entwickelte Me-thodik konnte polygene Risikoscores für die kardiovaskuläre Prävention integrieren. Im Falle der NMR-Metabolomik erschloss die entwickelte Methodik wertvolle Informa- tionen über den zukünftigen Ausbruch von Krankheiten. Unter Einsatz einer phänomen- weiten Risikomodellierung erwiesen sich elektronische Gesundheitsakten als Quelle prädik- tiver Information mit hoher systemischer Relevanz. Bei der Analyse von Fundusfotografien der Netzhaut wurden Krankheiten identifiziert für deren Vorhersage Netzhautinformationen genutzt werden könnten. Zusammengefasst zeigten die Ergebnisse das Potential neuronaler Risikomodelle die medizinische Praxis in Richtung einer datengesteuerten, präventionsori- entierten Medizin zu verändern

    Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review

    Get PDF
    Endometrial cancer is the most common gynaecological malignancy in developed countries. Over 382,000 new cases were diagnosed worldwide in 2018, and its incidence and mortality are constantly rising due to longer life expectancy and life style factors including obesity. Two major improvements are needed in the management of patients with endometrial cancer, i.e., the development of non/minimally invasive tools for diagnostics and prognostics, which are currently missing. Diagnostic tools are needed to manage the increasing number of women at risk of developing the disease. Prognostic tools are necessary to stratify patients according to their risk of recurrence pre-preoperatively, to advise and plan the most appropriate treatment and avoid over/under-treatment. Biomarkers derived from proteomics and metabolomics, especially when derived from non/minimally-invasively collected body fluids, can serve to develop such prognostic and diagnostic tools, and the purpose of the present review is to explore the current research in this topic. We first provide a brief description of the technologies, the computational pipelines for data analyses and then we provide a systematic review of all published studies using proteomics and/or metabolomics for diagnostic and prognostic biomarker discovery in endometrial cancer. Finally, conclusions and recommendations for future studies are also given
    corecore